Comparing survival and clinical characteristics of patients with non-small cell lung cancer who received immune checkpoint inhibitor therapy less than and more than 2 years

被引:0
|
作者
Rose, Brandon Edward
Edwards, Kyle
Kareff, Samuel A.
Ramos, Leana
El-Abbar, Nora
Lopes, Gilberto
Rodriguez, Estelamari
机构
[1] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA
[2] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
[3] Univ Miami, Sylvester Comprehens Canc Ctr, Jackson Mem Hosp, Miami, FL USA
[4] Univ Miami, Miami, FL USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e21214
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Integration of proteomic and clinical data for the prediction of response to immune checkpoint inhibitor therapy in non-small cell lung cancer.
    Shaked, Yuval
    Harel, Michal
    Lahav, Coren
    Jacob, Eyal
    Sela, Itamar
    Yahalom, Galit
    Elon, Yehonatan
    Sharon, Ofer
    Kamer, Iris
    Bar, Haim
    Dicker, Adam P.
    Bar, Jair
    Katzenelson, Rivka
    Wolf, Ido
    Gottfried, Maya
    Abu-Amana, Mahmud
    Agbarya, Abed
    Nechushtan, Hovav
    Moskovitz, Mor Tal
    Zer, Alona
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [42] The mechanism and risk factors for immune checkpoint inhibitor pneumonitis in non-small cell lung cancer patients
    Xiaoyang Zhai
    Jian Zhang
    Yaru Tian
    Ji Li
    Wang Jing
    Hongbo Guo
    Hui Zhu
    Cancer Biology & Medicine, 2020, 17 (03) : 599 - 611
  • [43] Subsequent systemic therapy for non-small cell lung cancer patients with immune checkpoint inhibitor-related interstitial lung disease
    Sato, Yusuke
    Watanabe, Satoshi
    Ota, Takeshi
    Kushiro, Kohei
    Fujisaki, Toshiya
    Takahashi, Miho
    Ohtsubo, Aya
    Shoji, Satoshi
    Nozaki, Koichiro
    Ichikawa, Kosuke
    Hokari, Satoshi
    Kondo, Rie
    Hayashi, Masachika
    Ishikawa, Hiroyuki
    Miyabayashi, Takao
    Abe, Tetsuya
    Miura, Satoru
    Tanaka, Hiroshi
    Okajima, Masaaki
    Terada, Masaki
    Ishida, Takashi
    Iwashima, Akira
    Sato, Kazuhiro
    Yoshizawa, Hirohisa
    Aoki, Nobumasa
    Ohshima, Yasuyoshi
    Koya, Toshiyuki
    Kikuchi, Toshiaki
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (07) : 3132 - +
  • [44] Efficacy and safety of immune checkpoint inhibitor monotherapy in elderly patients with non-small cell lung cancer
    Chikaishi, Yasuhiro
    Inoue, Masaaki
    Kusanagi, Kasumi
    Honda, Yohei
    Yoshida, Junichi
    Tanaka, Masao
    AGING MEDICINE, 2021, 4 (01) : 42 - 46
  • [45] Clinical characteristics and therapeutic effects of checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer
    Pang, Li
    Xie, Mei
    Ma, Xidong
    Huang, Aiben
    Song, Jialin
    Yao, Jie
    Deng, Hui
    Zhang, Duchao
    Zang, Xuelei
    Ren, Fangping
    Gao, Jie
    Wu, Chongchong
    Wang, Yuanyong
    Zhang, Xin
    Bao, Xinyu
    Pan, Lei
    Xue, Xinying
    BMC CANCER, 2023, 23 (01)
  • [46] The mechanism and risk factors for immune checkpoint inhibitor pneumonitis in non-small cell lung cancer patients
    Xiaoyang Zhai
    Jian Zhang
    Yaru Tian
    Ji Li
    Wang Jing
    Hongbo Guo
    Hui Zhu
    Cancer Biology & Medicine , 2020, (03) : 599 - 611
  • [47] Immune checkpoint inhibitor efficacy and safety in elderly non-small cell lung cancer patients.
    Watanabe, Hiromi
    Kubo, Toshio
    Ninomiya, Kiichiro
    Minami, Daisuke
    Kudo, Kenichiro
    Murakami, Etsuko
    Ochi, Nobuaki
    Ninomiya, Takashi
    Harada, Daijiro
    Yasugi, Masayuki
    Ichihara, Eiki
    Ohashi, Kadoaki
    Fujiwara, Keiichi
    Hotta, Katsuyuki
    Tabata, Masahiro
    Maeda, Yoshinobu
    Kiura, Katsuyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [48] Clinical characteristics and therapeutic effects of checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer
    Li Pang
    Mei Xie
    Xidong Ma
    Aiben Huang
    Jialin Song
    Jie Yao
    Hui Deng
    Duchao Zhang
    Xuelei Zang
    Fangping Ren
    Jie Gao
    Chongchong Wu
    Yuanyong Wang
    Xin Zhang
    Xinyu Bao
    Lei Pan
    Xinying Xue
    BMC Cancer, 23
  • [49] The mechanism and risk factors for immune checkpoint inhibitor pneumonitis in non-small cell lung cancer patients
    Zhai, Xiaoyang
    Zhang, Jian
    Tian, Yaru
    Li, Ji
    Jing, Wang
    Guo, Hongbo
    Zhu, Hui
    CANCER BIOLOGY & MEDICINE, 2020, 17 (03) : 599 - 611
  • [50] Retrospective Efficacy Analysis of Immune Checkpoint Inhibitor Rechallenge in Patients with Non-Small Cell Lung Cancer
    Katayama, Yuki
    Shimamoto, Takayuki
    Yamada, Tadaaki
    Takeda, Takayuki
    Yamada, Takahiro
    Shiotsu, Shinsuke
    Chihara, Yusuke
    Hiranuma, Osamu
    Iwasaku, Masahiro
    Kaneko, Yoshiko
    Uchino, Junji
    Takayama, Koichi
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (01)